AusperBio to Present Two Posters on AHB-137, a Novel Antisense Oligonucleotide for Hepatitis B at EASL™ Congress 2023 ...Middle East

Data will highlight the preclinical antiviral activity, pharmacokinetic property, and safety profile of AHB-137, a potential best-in-class antisense oligonucleotide (ASO) for the treatment of chronic Hepatitis B (CHB). SAN FRANCISCO, June 12, 2023 /PRNewswire/ -- Ausper Biopharma Co., Ltd....

Hence then, the article about ausperbio to present two posters on ahb 137 a novel antisense oligonucleotide for hepatitis b at easl congress 2023 was published today ( Monday 12/06/2023 - 10:12 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio to Present Two Posters on AHB-137, a Novel Antisense Oligonucleotide for Hepatitis B at EASL™ Congress 2023 )

Also on site :

• ‘American Idol’ Alum Ruben Studdard Stuns Fans With Weight-Loss Transformation After Hitting 462 Pounds
• Shoppers Say This $27 Lemon Vase Looks Like ‘Italian Pottery,’ Capturing the Mediterranean Farmhouse Aesthetic
• One of the VC world’s biggest stars is doubling down on sports in a big way, and there’s a compelling tax reason behind the strategy